Max M. Sogaard

SCION DTU Science Park, Agern Allé, 12970 Hørsholm
Horsholm, 1297, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Carbohydrate fatty acid monosulphate ester adjuvant enhances the immunogenicity of influenza antigens via TLR4/2-dependent mechanisms.

Carbohydrate fatty acid monosulphate ester adjuvant enhances the immunogenicity of influenza antigens via TLR4/2-dependent mechanisms.

Journal: Frontiers in immunology

Published: January 13, 2026

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages.

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages.

Journal: Communications biology

Published: October 31, 2023

Characterization of SARS-CoV-2 humoral immune response in a subject with unique sampling: A case report.

Characterization of SARS-CoV-2 humoral immune response in a subject with unique sampling: A case report.

Journal: Immunity, inflammation and disease

Published: April 02, 2023

First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2.

First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2.

Journal: The Lancet. Microbe

Published: September 05, 2022

SARS-CoV-2 RBD-Specific Antibodies Induced Early in the Pandemic by Natural Infection and Vaccination Display Cross-Variant Binding and Inhibition.

SARS-CoV-2 RBD-Specific Antibodies Induced Early in the Pandemic by Natural Infection and Vaccination Display Cross-Variant Binding and Inhibition.

Journal: Viruses

Published: July 13, 2022

Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants.

Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants.

Journal: mBio

Published: October 12, 2021

SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.

SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: March 23, 2021

Site-specific O-glycosylation analysis of SARS-CoV-2 spike protein produced in insect and human cells.

Site-specific O-glycosylation analysis of SARS-CoV-2 spike protein produced in insect and human cells.

Journal: bioRxiv : the preprint server for biology

Published: February 10, 2021

Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells.

Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells.

Journal: Viruses

Published: February 03, 2021

Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.

Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.

Journal: Nature communications

Published: July 17, 2020

Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.

Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.

Journal: Cells

Published: July 08, 2019

Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes.

Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes.

Journal: Cellular microbiology

Published: December 20, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026